Analyzing the Efficacy of Inotuzumab Ozogamicin as Induction Therapy for Treating Philadelphia Chromosome–Negative B-ALL in Patients Above 55 Years
The following is a summary of “Inotuzumab Ozogamicin as Induction Therapy for Patients Older...
Read More